跳至主要内容
临床试验/JPRN-UMIN000025469
JPRN-UMIN000025469未知未知

Effect of gastric acid suppression by use of vonoplazan - Effect of gastric acid suppression by use of vonoplazan

ational Hospital Organization Hakodate Hospital0 个研究点目标入组 10 人开始时间: 2016年12月31日最近更新:

试验速览

阶段
未知
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 45years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • (1)Subjects with history of gastric ulcer or duodenum ulcer (2)Subjects with a serious complication of liver failure (3)Subjects with a serious complication of renal failure (4)Subjects with a serious complication of heart failure (5)Subjects treated with atazanavir sulfate (Reyataz) or rilpivirine hydrochloride (Edurant) (6)Subjects with Zollinger-Ellison syndrome (7)Subjects with history of surgery that affects gastric-acid secretion (8)Subjects with a history of allergy to the investigational product (9)Subjects with atrophic gastritis, gastric tumor, gastric ulcer or duodenum ulcer by endoscopic examination.

研究者

发起方
ational Hospital Organization Hakodate Hospital

相似试验